In vivo administration of recombinant IL-2 to individuals infected by HIV down-modulates the binding and expression of the transcription factors Ying-Yang-1 and leader binding protein-1/late simian virus 40 factor

Chiara Bovolenta, Laura Camorali, Alessandro L. Lorini, Giuliana Vallanti, Silvia Ghezzi, Giuseppe Tambussi, Adriano Lazzarin, Guido Poli

Research output: Contribution to journalArticle

Abstract

Leader binding protein-1 (LBP-1)/late SV40 factor (LSF) and ying yang-1 (YY1) transcription factors are involved in the regulation of HIV expression. In particular, YY1 and LBP-1 have been shown to cooperate in repressing HIV- 1-long terminal repeat reporter gene expression by in vitro cotransfection experiments. However, no information is available on the levels of expression and activation of these transcription factors in PBMC of HIV-infected individuals. Therefore, we have evaluated the expression and DNA binding activity of YY1 and LBP-1 (LSF) in PBMC of HIV-infected individuals before, during, and after administration of IL-2 in association with antiretroviral therapy (ART), a regimen under consideration for broad clinical use in this disease based on its ability to stably raise the absolute number of circulating CD4+ T lymphocytes. Both YY1- and LBP-1 (LSF)-DNA binding were profoundly down-modulated during administration of IL-2/ART, and a proteolytic activity probably responsible for the reduced expression of the two cellular transcription factors was found activated in PBMC of individuals receiving the immunotherapeutic regimen. This study is the first evidence of modulation of cellular transcription factors following IL-2/ART administration and provides a potential correlate of the transient raises in plasma viremia early reported in patients receiving IL-2 in the absence of ART, thus underscoring the importance of always administering this cytokine to HIV-infected individuals together with potent antiretrovirals.

Original languageEnglish
Pages (from-to)6892-6897
Number of pages6
JournalJournal of Immunology
Volume163
Issue number12
Publication statusPublished - 1999

Fingerprint

Simian virus 40
Interleukin-2
Carrier Proteins
Transcription Factors
HIV
HIV Long Terminal Repeat
Viremia
DNA
Therapeutics
Reporter Genes
HIV-1
Cytokines
T-Lymphocytes
Gene Expression

ASJC Scopus subject areas

  • Immunology

Cite this

In vivo administration of recombinant IL-2 to individuals infected by HIV down-modulates the binding and expression of the transcription factors Ying-Yang-1 and leader binding protein-1/late simian virus 40 factor. / Bovolenta, Chiara; Camorali, Laura; Lorini, Alessandro L.; Vallanti, Giuliana; Ghezzi, Silvia; Tambussi, Giuseppe; Lazzarin, Adriano; Poli, Guido.

In: Journal of Immunology, Vol. 163, No. 12, 1999, p. 6892-6897.

Research output: Contribution to journalArticle

@article{db5a1475c95e4068b112bb759cb7b08e,
title = "In vivo administration of recombinant IL-2 to individuals infected by HIV down-modulates the binding and expression of the transcription factors Ying-Yang-1 and leader binding protein-1/late simian virus 40 factor",
abstract = "Leader binding protein-1 (LBP-1)/late SV40 factor (LSF) and ying yang-1 (YY1) transcription factors are involved in the regulation of HIV expression. In particular, YY1 and LBP-1 have been shown to cooperate in repressing HIV- 1-long terminal repeat reporter gene expression by in vitro cotransfection experiments. However, no information is available on the levels of expression and activation of these transcription factors in PBMC of HIV-infected individuals. Therefore, we have evaluated the expression and DNA binding activity of YY1 and LBP-1 (LSF) in PBMC of HIV-infected individuals before, during, and after administration of IL-2 in association with antiretroviral therapy (ART), a regimen under consideration for broad clinical use in this disease based on its ability to stably raise the absolute number of circulating CD4+ T lymphocytes. Both YY1- and LBP-1 (LSF)-DNA binding were profoundly down-modulated during administration of IL-2/ART, and a proteolytic activity probably responsible for the reduced expression of the two cellular transcription factors was found activated in PBMC of individuals receiving the immunotherapeutic regimen. This study is the first evidence of modulation of cellular transcription factors following IL-2/ART administration and provides a potential correlate of the transient raises in plasma viremia early reported in patients receiving IL-2 in the absence of ART, thus underscoring the importance of always administering this cytokine to HIV-infected individuals together with potent antiretrovirals.",
author = "Chiara Bovolenta and Laura Camorali and Lorini, {Alessandro L.} and Giuliana Vallanti and Silvia Ghezzi and Giuseppe Tambussi and Adriano Lazzarin and Guido Poli",
year = "1999",
language = "English",
volume = "163",
pages = "6892--6897",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

TY - JOUR

T1 - In vivo administration of recombinant IL-2 to individuals infected by HIV down-modulates the binding and expression of the transcription factors Ying-Yang-1 and leader binding protein-1/late simian virus 40 factor

AU - Bovolenta, Chiara

AU - Camorali, Laura

AU - Lorini, Alessandro L.

AU - Vallanti, Giuliana

AU - Ghezzi, Silvia

AU - Tambussi, Giuseppe

AU - Lazzarin, Adriano

AU - Poli, Guido

PY - 1999

Y1 - 1999

N2 - Leader binding protein-1 (LBP-1)/late SV40 factor (LSF) and ying yang-1 (YY1) transcription factors are involved in the regulation of HIV expression. In particular, YY1 and LBP-1 have been shown to cooperate in repressing HIV- 1-long terminal repeat reporter gene expression by in vitro cotransfection experiments. However, no information is available on the levels of expression and activation of these transcription factors in PBMC of HIV-infected individuals. Therefore, we have evaluated the expression and DNA binding activity of YY1 and LBP-1 (LSF) in PBMC of HIV-infected individuals before, during, and after administration of IL-2 in association with antiretroviral therapy (ART), a regimen under consideration for broad clinical use in this disease based on its ability to stably raise the absolute number of circulating CD4+ T lymphocytes. Both YY1- and LBP-1 (LSF)-DNA binding were profoundly down-modulated during administration of IL-2/ART, and a proteolytic activity probably responsible for the reduced expression of the two cellular transcription factors was found activated in PBMC of individuals receiving the immunotherapeutic regimen. This study is the first evidence of modulation of cellular transcription factors following IL-2/ART administration and provides a potential correlate of the transient raises in plasma viremia early reported in patients receiving IL-2 in the absence of ART, thus underscoring the importance of always administering this cytokine to HIV-infected individuals together with potent antiretrovirals.

AB - Leader binding protein-1 (LBP-1)/late SV40 factor (LSF) and ying yang-1 (YY1) transcription factors are involved in the regulation of HIV expression. In particular, YY1 and LBP-1 have been shown to cooperate in repressing HIV- 1-long terminal repeat reporter gene expression by in vitro cotransfection experiments. However, no information is available on the levels of expression and activation of these transcription factors in PBMC of HIV-infected individuals. Therefore, we have evaluated the expression and DNA binding activity of YY1 and LBP-1 (LSF) in PBMC of HIV-infected individuals before, during, and after administration of IL-2 in association with antiretroviral therapy (ART), a regimen under consideration for broad clinical use in this disease based on its ability to stably raise the absolute number of circulating CD4+ T lymphocytes. Both YY1- and LBP-1 (LSF)-DNA binding were profoundly down-modulated during administration of IL-2/ART, and a proteolytic activity probably responsible for the reduced expression of the two cellular transcription factors was found activated in PBMC of individuals receiving the immunotherapeutic regimen. This study is the first evidence of modulation of cellular transcription factors following IL-2/ART administration and provides a potential correlate of the transient raises in plasma viremia early reported in patients receiving IL-2 in the absence of ART, thus underscoring the importance of always administering this cytokine to HIV-infected individuals together with potent antiretrovirals.

UR - http://www.scopus.com/inward/record.url?scp=0032760830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032760830&partnerID=8YFLogxK

M3 - Article

C2 - 10586091

AN - SCOPUS:0032760830

VL - 163

SP - 6892

EP - 6897

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -